FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine, pharmacology and chemical-pharmaceutical industry, specifically to novel compositions for treating and preventing respiratory diseases containing 2-(imidazol-4-yl)-ethanamide of pentane dihydro-1,5-acid and N,N'-bis-[2-(1H-imidazol-4-yl)ethyl]pentane diamide and/or their pharmaceutically acceptable salts, a pharmaceutical composition based on said compositions, a medicinal agent based on said compositions or said pharmaceutical composition and a ready dosage form based on said compositions, said pharmaceutical composition or said medicinal agent. Invention also relates to the use of said compositions, a pharmaceutical composition, a medicinal agent or a ready dosage form for treating and preventing influenza and ARVI.
EFFECT: treatment and prevention of viral diseases.
13 cl, 6 ex, 4 tbl
Authors
Dates
2021-04-19—Published
2020-04-14—Filed